| Home | Search | Study Topics | Glossary |
|
|
|
 |
| Return to Search Results |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Rabin Medical Center |
| Information provided by: | Rabin Medical Center |
| ClinicalTrials.gov Identifier: | NCT00768820 |
Purpose
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
| Condition | Intervention | Phase |
|
Velocardiofacial Syndrome Williams Syndrome Fragile X Syndrome |
Drug: methylphenidate, fluoxetin, risperidone |
Phase IV |
| Genetics Home Reference related topics: | 22q11.2 deletion syndrome familial encephalopathy with neuroserpin inclusion bodies fragile X syndrome L1 syndrome Williams syndrome |
| MedlinePlus related topics: | Fragile X Syndrome |
| Drug Information available for: | Risperidone Methylphenidate hydrochloride Methylphenidate |
| Study Type: | Interventional |
| Study Design: | Diagnostic, Open Label, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors |
| Estimated Enrollment: | 400 |
| Study Start Date: | May 2001 |
| Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
| 1: Experimental |
Drug: methylphenidate, fluoxetin, risperidone
first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate
|
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Doron Gothelf, MD | 972-03-9253186 | gothelf@post.tau.ac.il |
| Israel | |||||
| Schneider Children's Mediac Center of Israel | Recruiting | ||||
| Petach-Tikva, Israel, 49202 | |||||
| Contact: Doron Gothelf, MD 972-03-9253186 | |||||
| Rabin Medical Center |
More Information
| Responsible Party: | Rabin Medical Center ( Doron Gothelf ) |
| Study ID Numbers: | SCMCI082455CTIL |
| First Received: | October 7, 2008 |
| Last Updated: | October 7, 2008 |
| ClinicalTrials.gov Identifier: | NCT00768820 |
| Health Authority: | Israel: Israeli Health Ministry Pharmaceutical Administration |
|
|
|
|
|
|
